These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25766585)

  • 1. Antiangiogenic Effectiveness of the Urokinase Receptor-Derived Peptide UPARANT in a Model of Oxygen-Induced Retinopathy.
    Dal Monte M; Rezzola S; Cammalleri M; Belleri M; Locri F; Morbidelli L; Corsini M; Paganini G; Semeraro F; Cancarini A; Rusciano D; Presta M; Bagnoli P
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2392-407. PubMed ID: 25766585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Urokinase Receptor-Derived Peptide UPARANT Mitigates Angiogenesis in a Mouse Model of Laser-Induced Choroidal Neovascularization.
    Cammalleri M; Dal Monte M; Locri F; Lista L; Aronsson M; Kvanta A; Rusciano D; De Rosa M; Pavone V; André H; Bagnoli P
    Invest Ophthalmol Vis Sci; 2016 May; 57(6):2600–2611. PubMed ID: 27168367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
    Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gaining insight on mitigation of rubeosis iridis by UPARANT in a mouse model associated with proliferative retinopathy.
    Locri F; Pesce NA; Aronsson M; Cammalleri M; De Rosa M; Pavone V; Bagnoli P; Kvanta A; Dal Monte M; André H
    J Mol Med (Berl); 2020 Nov; 98(11):1629-1638. PubMed ID: 32940719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Urokinase Receptor-Derived Peptide UPARANT Recovers Dysfunctional Electroretinogram and Blood-Retinal Barrier Leakage in a Rat Model of Diabetes.
    Cammalleri M; Locri F; Marsili S; Dal Monte M; Pisano C; Mancinelli A; Lista L; Rusciano D; De Rosa M; Pavone V; Bagnoli P
    Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):3138-3148. PubMed ID: 28632880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo inhibition of proangiogenic retinal phenotype by an antisense oligonucleotide downregulating uPAR expression.
    Lulli M; Cammalleri M; Granucci I; Witort E; Bono S; Di Gesualdo F; Lupia A; Loffredo R; Casini G; Dal Monte M; Capaccioli S
    Biochem Biophys Res Commun; 2017 Aug; 490(3):977-983. PubMed ID: 28666875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic Retinopathy in the Spontaneously Diabetic Torii Rat: Pathogenetic Mechanisms and Preventive Efficacy of Inhibiting the Urokinase-Type Plasminogen Activator Receptor System.
    Cammalleri M; Dal Monte M; Locri F; Marsili S; Lista L; De Rosa M; Pavone V; Rusciano D; Bagnoli P
    J Diabetes Res; 2017; 2017():2904150. PubMed ID: 29464181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
    You JJ; Yang CH; Huang JS; Chen MS; Yang CM
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy.
    Rezzola S; Corsini M; Chiodelli P; Cancarini A; Nawaz IM; Coltrini D; Mitola S; Ronca R; Belleri M; Lista L; Rusciano D; De Rosa M; Pavone V; Semeraro F; Presta M
    Diabetologia; 2017 Apr; 60(4):719-728. PubMed ID: 28083635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetyl-11-keto-β-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
    Lulli M; Cammalleri M; Fornaciari I; Casini G; Dal Monte M
    Exp Eye Res; 2015 Jun; 135():67-80. PubMed ID: 25913458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of β1/2 adrenergic receptor deletion in a model of oxygen-induced retinopathy.
    Dal Monte M; Cammalleri M; Mattei E; Filippi L; Bagnoli P
    Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):59-73. PubMed ID: 25503457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis.
    Nakao S; Arima M; Ishikawa K; Kohno R; Kawahara S; Miyazaki M; Yoshida S; Enaida H; Hafezi-Moghadam A; Kono T; Ishibashi T
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4323-8. PubMed ID: 22661475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleiotropic effects of YC-1 selectively inhibit pathological retinal neovascularization and promote physiological revascularization in a mouse model of oxygen-induced retinopathy.
    DeNiro M; Al-Halafi A; Al-Mohanna FH; Alsmadi O; Al-Mohanna FA
    Mol Pharmacol; 2010 Mar; 77(3):348-67. PubMed ID: 20008515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
    Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of a novel non-peptide αvβ3 integrin antagonist for pathological retinal angiogenesis in mice.
    Li YJ; Li XH; Wang LF; Kuang X; Hang ZX; Deng Y; Du JR
    Exp Eye Res; 2014 Dec; 129():119-26. PubMed ID: 25446322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockout of αA-crystallin inhibits ocular neovascularization.
    Xu Q; Bai Y; Huang L; Zhou P; Yu W; Zhao M
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):816-26. PubMed ID: 25574047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Mechanisms Mediating Antiangiogenic Action of the Urokinase Receptor-Derived Peptide UPARANT in Human Retinal Endothelial Cells.
    Motta C; Lupo G; Rusciano D; Olivieri M; Lista L; De Rosa M; Pavone V; Anfuso CD
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5723-5735. PubMed ID: 27787560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal proteome analysis in a mouse model of oxygen-induced retinopathy.
    Kim SJ; Jin J; Kim YJ; Kim Y; Yu HG
    J Proteome Res; 2012 Nov; 11(11):5186-203. PubMed ID: 23039900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E2 and E3, but Not E4, Promote Retinal Pathologic Neovascularization.
    Masuda T; Shimazawa M; Hashimoto Y; Kojima A; Nakamura S; Suemori S; Mochizuki K; Kawakami H; Kawase K; Hara H
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1208-1217. PubMed ID: 28241308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of neovascularization and expression shift of pro-/anti-angiogenic vascular endothelial growth factor isoforms after intravitreal bevacizumab injection in oxygen-induced-retinopathy mouse model.
    Shi X; Zhao M; Xie WK; Liang JH; Miao YF; DU W; Li XX
    Chin Med J (Engl); 2013 Jan; 126(2):345-52. PubMed ID: 23324288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.